# SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF)

> **NCT03842917** · — · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 26 (actual)

## Conditions studied

- Patient Starting Bevacizumab
- Cancer

## Interventions

- **OTHER:** Biological samples
- **OTHER:** Blood pressure measurement

## Key facts

- **NCT ID:** NCT03842917
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-26
- **Primary completion:** 2022-04-27
- **Final completion:** 2022-06-15
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03842917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03842917, "SAlt Diet and Various Biomarkers Effects on Blood Pressure and Proteinuria During Inhibition of VEGF)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03842917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*